# FDA 483 - Huiqiang Sun Huang - February 14, 2025

Source: https://www.globalkeysolutions.net/records/483/huiqiang-sun-huang/48f74644-7fa9-4738-81e2-0dc8ac5cfe66

> FDA 483 for Huiqiang Sun Huang on February 14, 2025. Product: drugs. Access full analysis and detailed observations.

---

## Details

- Record Type: 483
- Company Name: Huiqiang Sun Huang
- Inspection Date: 2025-02-14
- Product Type: drugs
- Office Name: Division of Clinical Evidence and Analysis 1 (Clinical Policy and Quality)

## Related Documents

- [483 - 2025-02-14](https://www.globalkeysolutions.net/records/483/huiqiang-sun-huang/e12f0a35-ccdf-4b6b-82ab-1eb5fb398442)

## Related Officers

- [Janete F. Guardia](https://www.globalkeysolutions.net/people/janete-f-guardia/2405f83f-7ea9-4056-afbd-7d9c00a6e169)
- [Tonia F. Bernard](https://www.globalkeysolutions.net/people/tonia-f-bernard/607c8dae-63cb-491a-8d7d-ddfa0ee1b67d)

Company: https://www.globalkeysolutions.net/companies/huiqiang-sun-huang/3c49cc1b-7120-4374-b392-486dbef558db

Office: https://www.globalkeysolutions.net/offices/division-of-clinical-evidence-and-analysis-1-clinical-policy-and-quality/5f95da17-30bb-423f-b892-5ea041823fbd